Replies to post #8444 on GTC Biotherapeutics (fka GTCB)

[pharm]

Dew, you can add to this list that Pharming overtook since yesterday the intellectual properties of Infigen. These patents circel mainly around nuclear transfer.

[DewDiligence]

Notes on Pharming Group, n.v.

[Added EMEA rejection of Rhucin appeal.]

#msg-27808107 EMEA rejects Rhucin appeal
#msg-26347101 Pharming appeals Rhucin rejection, reiterates US plans
#msg-22208171 Phase-3 Rhucin data
#msg-22482530 Pharming seeks US Rhucin partner

#msg-26844990 4Q07 results
#msg-20830051 Pipeline overview

#msg-18949245 IP cross-license with GTC
#msg-27220955 Pharming licenses cattle IP from ACTC